Julia Brinkmann, MD, MBA

Global Medical Strategy Lead @Pfizer

Germany

About

MD with ~20 years of experience in the pharmaceutical industry incl strategic partnerships/alliances, clinics, insurance and research. MBA. Pragmatic, strong communicator, team player, proactive. Understanding of the overall drug development process and regulatory path for oncology products in various markets. Able to evaluate, interpret and present highly complex data from clinical trials. Ability to work in cross functional groups and teams with a complex matrix organization. Experience of financial and resource planning and management. Excellent presentation and communication skills with an ability to meet the scientific, commercial needs. Ability to co-ordinate with multiple stakeholders across geographies of various markets both within and outside the organization. Enthusiastic about bringing science and entrepreneurial success together for improving patients´lives. Key skills include identifying key drivers of change in the life sciences industry and applying strategies and emerging technologies needed to accelerate results when leading clinical development projects.

Experience

  • Pfizer (7 yrs 10 mos)
    • Global Medical Launch Lead MIBC
      Feb 2026 - Present · 6 mos

    • Global Medical Strategy Lead NMIBC
      Mar 2022 - Present · 4 yrs 5 mos

      Cross-functional leader responsible for developing and executing medical cross-functional strategies at portfolio and program levels. Serving as medical subject matter expert in global program teams to advice on program and life-cycle strategies. Medical and scientific peer-to-peer interactions with external key stakeholders, including clinical/scientific experts, cooperative groups and professional networks; program and portfolio strategies, leadership with clinical teams, and commercial teams and execution of specific projects. Lead/Drive development and execution of key medical affairs deliverables including but not limited to: external scientific communication, evidence generation, post-approval phase 4 studies, standard medical inquiry responses.

    • Global Product Development Lung Cancer- Medical Director Growth Gig
      Aug 2025 - Mar 2026 · 8 mos

      Research&Development Medical Monitoring Medical Director NSCLC

  • Specialist Medical Department at KKH Kaufmännische Krankenkasse
    Jun 2017 - Sep 2018 · 1 yr 4 mos

  • Clinical Pharmacologist at Hannover Medical School
    Jan 2011 - May 2017 · 6 yrs 5 mos

    Board Accredited Clinical Pharmacologist

  • Pediatrician at Kinderkrankenhaus Auf Der Bult
    Dec 2009 - Dec 2010 · 1 yr 1 mo

  • Pharmaceutical Sales Representative at AstraZeneca
    2002 - 2003 · 1 yr